Deprecated: abs(): Passing null to parameter #1 ($num) of type int|float is deprecated in /home/individends/public_html/financial_analysis.php on line 303

Profitability Metrics

Gross Margin
86.27%
Operating Margin
0.67%
Net Margin
-3.96%

Efficiency Metrics

Revenue per Expense Ratio
1.08
R&D as % of Revenue
0.00%

Earnings Quality

EBITDA Margin
0.00%
Income Tax Rate
163,500,000.0%
EPS
-0.1100000000

Balance Sheet Analysis

Current Ratio
0.19
Cash Ratio
0.24
Working Capital
$-1.27B
Debt to Equity
10.86
Debt to Assets
90.08%
Equity Ratio
8.29%

Cash Flow Analysis

Operating Cash Flow Ratio
-1,273.4%
Free Cash Flow Ratio
-1,273.4%
CapEx to Revenue
0.00%
Dividends Paid
$93.58M
Stock Buybacks
$5.00K
Total Shareholder Returns
$93.58M
Cash Position Change
11.97%

Key Takeaways (2023 FY)

  • Maintained positive net income growth despite revenue changes
  • Increased R&D investment by 100.00%

Detailed Growth Metrics

Core Performance

Revenue
686.29%
Net Income
96.18%
EPS
92.14%
Operating Income
-99.74%

Operational Efficiency

R&D Expenses
100.00%
SG&A Expenses
-9.01%
Operating Cash Flow
-1,348.77%
Free Cash Flow
-1,348.77%

Balance Sheet Health

Assets
11.31%
Debt
9.31%
Book Value per Share
11.85%
Inventory
-100.00%

Shareholder Returns

Dividends per Share
-15.53%
Shares Outstanding
-0.81%

Long Term Trends

3Y Revenue/Share
142.73%
5Y Revenue/Share
-30.01%
3Y Dividend/Share
9.17%
5Y Dividend/Share
-8.53%